who is selling?, page-3

I see a steady slide with a step down into a cap raising price. If they decide to start US trials the cap raise may be significant unless they can pull a rabbit out of the hat and find a rich partner.

Playing out similar to ACL? with delay in income and trials were being held off but now the delay till trials could be funded from revenue just seems too long to wait for me. 20 mil cap raise?? will retail holders be screwed like they were by ACL?

I'm waiting and will try to pick the bottom but may just end up with a smelly finger!!